BFA
ASTX

BlackRock Fund Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

BlackRock Fund Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,174,298
Closed -$35.4M – 3905
2013
Q3 		$35.4M Buy
4,174,298
+885,669
+27% +$5.6M 0.01% 1573
2013
Q2 		$13.5M Buy
+3,288,629
New +$17.7M 0.01% 2079

BlackRock Fund Advisors's ASTX Position: Q4 2013 in Review

BlackRock Fund Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 4,174,298 shares — an estimated $35.4M sold.

BlackRock Fund Advisors first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $35.4M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BlackRock Fund Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BlackRock Fund Advisors sold 4,174,298 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $35.4M.
  • BlackRock Fund Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BlackRock Fund Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $35.4M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BlackRock Fund Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.